When overweight or obese people lose weight, using a low carb diet, they can have a significant reduction in inflammation throughout their body, as measured by three common markers….
Read More »How Should We Treat the Elderly with Diabetes?
More than one-quarter of all adults over age 65 have diabetes but there is little research on how to treat the disease in older adults….
Read More »Multivitamins Do Not Reduce Cardiovascular Events
A study with 15,000 middle-aged male physicians using multivitamins for more than 10 years showed no benefit in reducing cardiovascular events….
Read More »Being Black Doubles the Risk for Fatal Coronary Heart Disease
In an examination of the incidence of coronary heart disease in the U.S. by race and sex, black men and women had twice the rate of fatal CHD compared with white men and women….
Read More »Aliskiren Combo Fails in High-Risk Diabetes Patients
Adding the direct renin inhibitor aliskiren to either an angiotensin-receptor blocker (ARB) or an angiotensin-converting-enzyme (ACE) inhibitor didn’t reduce heart or kidney events in type 2 diabetes patients at risk for such complications….
Read More »Diabetes Treatment Can Start Earlier
Researchers at Sweden’s Lund University have identified a "promising candidate" for a test that will indicate an early risk for type 2 diabetes, up to 10 years before diagnosing….
Read More »Lifetime Risk of Developing Cardiovascular Disease Substantial
Even in men and women with an optimal cardiovascular disease (CVD) risk factor profile, the lifetime risk estimate for CVD is greater than 30%, and is more than 50% for men and women overall….
Read More »Higher Pulse Wave Velocity Seen in Well-Controlled Diabetes
Pulse wave velocity which can be a parameter in the evaluation of cerebrovascular disease risk correlated with white matter lesion volume even after adjustment for confounding variables….
Read More »Dabigatran versus Warfarin in Diabetic Patients with Atrial Fibrillation
The Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) was a randomized trial designed to compare two fixed doses of dabigatran, each administered in a blinded manner, with open-label use of warfarin in patients who had atrial fibrillation and were at increased risk for stroke….
Read More »Tight Glycemic Control Not Helpful after Kidney Transplant
For diabetic kidney recipients, early intensive glycemic control might reduce delayed graft function (DGF) but with a higher risk of rejection….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.